$ATER
Aterian, Inc. Stock $ater

$ater Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000156459022019333 Filed on May 10, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$41.67M	$48.14M
YoY Change	-13.43%	87.83%
Cost Of Revenue	$18.07M	$22.07M
YoY Change	-18.14%	43.97%
Gross Profit	$23.61M	$26.06M
YoY Change	-9.41%	153.06%
Gross Profit Margin	56.65%	54.14%
Selling, General & Admin	$32.52M	$36.05M
YoY Change	-9.81%	64.51%
% of Gross Profit	137.73%	138.33%
Research & Development	$1.144M	$2.124M
YoY Change	-46.14%	-6.84%
% of Gross Profit	4.85%	8.15%
Depreciation & Amortization	$1.846M	$1.200M
YoY Change	53.83%	2900.0%
% of Gross Profit	7.82%	4.6%
Operating Expenses	$30.88M	$2.124M
YoY Change	1354.05%	-91.22%
Operating Profit	-$7.277M	-$27.75M
YoY Change	-73.78%	99.7%
Interest Expense	$802.0K	$4.753M
YoY Change	-83.13%	319.51%
% of Operating Profit
Other Income/Expense, Net	-$5.810M	-$33.00K
YoY Change	17506.06%	32.0%
Pretax Income	-$42.78M	-$82.55M
YoY Change	-48.18%	449.25%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$42.78M	-$82.55M
YoY Change	-48.18%	449.25%
Net Earnings / Revenue	-102.65%	-171.5%
Basic Earnings Per Share	-$0.78
Diluted Earnings Per Share	-$775.8K	-$3.147M
COMMON SHARES
Basic Shares Outstanding	55.14M
Diluted Shares Outstanding	55.14M

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$44.28M	$35.00M
YoY Change	26.52%	148.23%
Cash & Equivalents	$44.28M	$35.00M
Short-Term Investments
Other Short-Term Assets	$13.44M	$24.60M
YoY Change	-45.37%	412.5%
Inventory	$75.43M	$55.03M
Prepaid Expenses
Receivables	$5.870M	$7.200M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$139.0M	$121.8M
YoY Change	14.13%	80.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.146M	$200.0K
YoY Change	473.0%	0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.726M	$3.600M
YoY Change	-24.28%	1700.0%
Total Long-Term Assets	$158.0M	$144.2M
YoY Change	9.57%	10200.0%
TOTAL ASSETS
Total Short-Term Assets	$139.0M	$121.8M
Total Long-Term Assets	$158.0M	$144.2M
Total Assets	$297.0M	$266.0M
YoY Change	11.66%	287.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$22.89M	$26.50M
YoY Change	-13.61%	22.12%
Accrued Expenses	$14.71M	$13.70M
YoY Change	7.39%	128.33%
Deferred Revenue
YoY Change
Short-Term Debt	$33.54M	$25.00M
YoY Change	34.18%	4.6%
Long-Term Debt Due		$21.60M
YoY Change		380.0%
Total Short-Term Liabilities	$99.16M	$106.0M
YoY Change	-6.45%	87.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$83.70M
YoY Change	-100.0%	819.78%
Other Long-Term Liabilities	$509.0K	$37.80M
YoY Change	-98.65%
Total Long-Term Liabilities	$509.0K	$121.5M
YoY Change	-99.58%	1235.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$99.16M	$106.0M
Total Long-Term Liabilities	$509.0K	$121.5M
Total Liabilities	$99.67M	$227.5M
YoY Change	-56.19%	246.27%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$197.4M	$38.47M
YoY Change
Total Liabilities & Shareholders Equity	$297.0M	$266.0M
YoY Change	11.66%	287.19%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$42.78M	-$82.55M
YoY Change	-48.18%	449.25%
Depreciation, Depletion And Amortization	$1.846M	$1.200M
YoY Change	53.83%	2900.0%
Cash From Operating Activities	-$13.17M	-$8.495M
YoY Change	55.03%	-50.3%
INVESTING ACTIVITIES
Capital Expenditures	-$16.00K	$20.00K
YoY Change	-180.0%	11.11%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$16.00K	-$15.30M
YoY Change	-99.9%	84900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$27.01M
YoY Change
Debt Paid & Issued, Net		$5.400M
YoY Change
Cash From Financing Activities	21.72M	38.50M
YoY Change	-43.6%	4694.65%
NET CHANGE
Cash From Operating Activities	-13.17M	-8.495M
Cash From Investing Activities	-16.00K	-15.30M
Cash From Financing Activities	21.72M	38.50M
Net Change In Cash	8.359M	14.61M
YoY Change	-42.77%	-189.6%
FREE CASH FLOW
Cash From Operating Activities	-$13.17M	-$8.495M
Capital Expenditures	-$16.00K	$20.00K
Free Cash Flow	-$13.15M	-$8.515M
YoY Change	54.48%	-50.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PrepaidExpenseAndOtherAssetsCurrent
CY2022Q1	ater	Operating Lease Liability Current Statements Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementsOfFinancialPositionExtensibleList	AccruedExpensesAndOtherLiabilitiesCurrent
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M7D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M12D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y8M12D
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2124000
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10976000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9541000
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	29020000
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	15645000
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2012000
CY2022Q1	ater	Gain Loss On Initial Issuance Of Equity GainLossOnInitialIssuanceOfEquity	-5835000
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1879000
CY2021Q1	ater	Loss On Initial Issuance Of Warrant LossOnInitialIssuanceOfWarrant	20147000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-82553000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-42776000
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.15
CY2022Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.78
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26225383
CY2022Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55141448
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	30000
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-171000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	30000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-171000
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-82523000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42947000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	23382000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-82553000
CY2021Q1	ater	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	40172000
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	39454000
CY2021Q1	ater	Issuance Of Restricted Stock Awards IssuanceOfRestrictedStockAwards	3427000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5804000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	30000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	38465000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-42776000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	767000
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27007000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	18982000
CY2022Q1	ater	Adjustments To Additional Paid In Capital Gain Loss On Initial Issuance Of Equity AdjustmentsToAdditionalPaidInCapitalGainLossOnInitialIssuanceOfEquity	5835000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1444000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-82553000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-42776000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1204000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1846000
CY2021Q1	ater	Provision For Sales Returns ProvisionForSalesReturns	-100000
CY2022Q1	ater	Provision For Sales Returns ProvisionForSalesReturns	109000
CY2021Q1	ater	Amortization Of Deferred Financing Costs And Debt Discounts AmortizationOfDeferredFinancingCostsAndDebtDiscounts	3963000
CY2022Q1	ater	Amortization Of Deferred Financing Costs And Debt Discounts AmortizationOfDeferredFinancingCostsAndDebtDiscounts	106000
CY2022Q1	ater	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	1879000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6899000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2865000
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	15645000
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2775000
CY2021Q1	ater	Loss In Connection With Warrant Fair Value LossInConnectionWithWarrantFairValue	30202000
CY2021Q1	ater	Loss On Initial Issuance Of Warrant LossOnInitialIssuanceOfWarrant	20147000
CY2022Q1	ater	Gain In Connection With Settlement Of Note Payable GainInConnectionWithSettlementOfNotePayable	2012000
CY2022Q1	ater	Gain Loss On Initial Issuance Of Equity GainLossOnInitialIssuanceOfEquity	-5835000
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	29020000
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1445000
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4608000
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15355000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12380000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4675000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-410000
CY2021Q1	ater	Increase Decrease In Accounts Payable Accrued And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities	17573000
CY2022Q1	ater	Increase Decrease In Accounts Payable Accrued And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities	95000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8495000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13170000
CY2021Q1	ater	Payments For Proceeds From Purchase Of Fixed Assets PaymentsForProceedsFromPurchaseOfFixedAssets	20000
CY2022Q1	ater	Payments For Proceeds From Purchase Of Fixed Assets PaymentsForProceedsFromPurchaseOfFixedAssets	16000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15300000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16000
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	8939000
CY2021Q1	ater	Proceeds From Cancellation Of Warrant ProceedsFromCancellationOfWarrant	16957000
CY2021Q1	ater	Proceeds From Payments For Stock Options Exercised ProceedsFromPaymentsForStockOptionsExercised	8749000
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	27007000
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	14531000
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30357000
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	12325000
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	33845000
CY2021Q1	ater	Payments Of Deferred Financing Costs PaymentsOfDeferredFinancingCosts	151000
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5400000
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	14025000
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1136000
CY2021Q1	ater	Payments Of Insurance Obligation Financing Activities PaymentsOfInsuranceObligationFinancingActivities	951000
CY2022Q1	ater	Payments Of Insurance Obligation Financing Activities PaymentsOfInsuranceObligationFinancingActivities	719000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38501000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21716000
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-99000
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-171000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14607000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8359000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30097000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38315000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44704000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46674000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34995000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44281000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9580000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2264000
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	129000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	129000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44704000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46674000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	252000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	357000
CY2021Q1	ater	Non Cash Consideration Paid To Contractors NonCashConsiderationPaidToContractors	3427000
CY2021Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	246000
CY2021Q1	ater	Debt Original Issue Discount DebtOriginalIssueDiscount	2475000
CY2021Q1	ater	Non Cash Fair Value Of Contingent Consideration NonCashFairValueOfContingentConsideration	16557000
CY2021Q1	ater	Discount Of Debt Relating To Warrants Issuance DiscountOfDebtRelatingToWarrantsIssuance	7740000
CY2021Q1	ater	Issuance Of Common Stock In Connection With Acquisition IssuanceOfCommonStockInConnectionWithAcquisition	39454000
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	767000
CY2022Q1	ater	Issuance Of Warrants In Connection With Offering IssuanceOfWarrantsInConnectionWithOffering	18982000
CY2022Q1	ater	Equity Fundraising Costs Not Paid EquityFundraisingCostsNotPaid	166000
CY2021Q1	ater	Common Stock Issued For Warrants CommonStockIssuedForWarrants	1125000
CY2022Q1	ater	Substantial Doubt About Going Concern Cash And Cash Equivalents SubstantialDoubtAboutGoingConcernCashAndCashEquivalents	44300000
CY2022Q1	ater	Substantial Doubt About Going Concern Accumulated Deficit SubstantialDoubtAboutGoingConcernAccumulatedDeficit	471700000
CY2022Q1	ater	Substantial Doubt About Going Concern Net Loss SubstantialDoubtAboutGoingConcernNetLoss	42800000
CY2022Q1	ater	Substantial Doubt About Going Concern Net Cash Used In Operating Activities SubstantialDoubtAboutGoingConcernNetCashUsedInOperatingActivities	13200000
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates<span style="font-weight:normal;">—</span><span style="color:#000000;font-weight:normal;"> Preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period covered by the financial statements and accompanying notes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.</span></p>
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48136000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41673000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48136000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41673000
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	29000000.0
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	700000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	700000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48079000
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	56449000
CY2021Q4	us-gaap	Other Inventory In Transit OtherInventoryInTransit	14966000
CY2022Q1	us-gaap	Other Inventory In Transit OtherInventoryInTransit	18976000
CY2021Q4	us-gaap	Inventory Net InventoryNet	63045000
CY2022Q1	us-gaap	Inventory Net InventoryNet	75425000
CY2021Q4	us-gaap	Other Inventory Warehouse OtherInventoryWarehouse	8400000
CY2022Q1	us-gaap	Other Inventory Warehouse OtherInventoryWarehouse	13800000
CY2021Q4	ater	Prepaid Inventory PrepaidInventory	4137000
CY2022Q1	ater	Prepaid Inventory PrepaidInventory	4093000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7998000
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	2264000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2440000
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1333000
CY2021Q4	ater	Consulting Fees ConsultingFees	2263000
CY2022Q1	ater	Consulting Fees ConsultingFees	905000
CY2021Q4	ater	Prepaid Logistics Costs PrepaidLogisticsCosts	2865000
CY2022Q1	ater	Prepaid Logistics Costs PrepaidLogisticsCosts	2789000
CY2022Q1	ater	Operating Lease Right Of Use Asset Current OperatingLeaseRightOfUseAssetCurrent	467000
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1331000
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1589000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21034000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13440000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	162000
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	216000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	331000
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	24000
CY2021Q4	ater	Accrued Logistics Costs Current AccruedLogisticsCostsCurrent	578000
CY2022Q1	ater	Accrued Logistics Costs Current AccruedLogisticsCostsCurrent	1269000
CY2021Q4	ater	Product Related Accruals ProductRelatedAccruals	2984000
CY2022Q1	ater	Product Related Accruals ProductRelatedAccruals	2492000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	678000
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	895000
CY2021Q4	ater	Sales Return Reserve SalesReturnReserve	590000
CY2022Q1	ater	Sales Return Reserve SalesReturnReserve	699000
CY2021Q4	ater	Accrued Fulfillment Expense AccruedFulfillmentExpense	744000
CY2022Q1	ater	Accrued Fulfillment Expense AccruedFulfillmentExpense	761000
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	967000
CY2022Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	98000
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4449000
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1865000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	338000
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	169000
CY2021Q4	ater	Accrued Legal Current AccruedLegalCurrent	375000
CY2022Q1	ater	Accrued Legal Current AccruedLegalCurrent	2790000
CY2022Q1	ater	Right Of Use Liabilities Current RightOfUseLiabilitiesCurrent	467000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5425000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3667000
CY2021Q4	ater	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	17621000
CY2022Q1	ater	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	15412000
CY2021Q3	us-gaap	Accounts Receivable Sale AccountsReceivableSale	65000000.0
CY2021Q3	ater	Warrants Prior To Day WarrantsPriorToDay	60 days
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2666667
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-138900000
CY2021Q1	us-gaap	Interest Expense InterestExpense	4753000
CY2022Q1	us-gaap	Interest Expense InterestExpense	802000
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	333000
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4420000
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-802000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-42776000
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26225383
CY2022Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55141448
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.15
CY2022Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.78
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5943489
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6009126
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	522905
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.25
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25971000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2492
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.72
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	520413
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.25
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25971000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	520065
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.25
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25971000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	520413
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.25
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	25971000
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y4M24D
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6899000
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2865000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-82553000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	700000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7489000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	64955000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72444000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72444000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9233000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	63211000
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	900000
CY2022Q1	ater	Issuance Of Common Stock For Settlement Of Seller Note IssuanceOfCommonStockForSettlementOfSellerNote	292887
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2000000.0
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48136000
CY2021Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	52736000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27751000
CY2021Q1	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-27369000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	22531000
CY2021	ater	Acquisition Date Fair Value Of Contingent Earn Out Liabilities And Inventory To Be Settled In Shares AcquisitionDateFairValueOfContingentEarnOutLiabilitiesAndInventoryToBeSettledInShares	20971000
CY2021	ater	Business Combination Contingent Consideration Change In Fair Value Of Contingent Earn Out Liabilities BusinessCombinationContingentConsiderationChangeInFairValueOfContingentEarnOutLiabilities	-30529000
CY2021	ater	Contingent Consideration Earn Out Payments ContingentConsiderationEarnOutPayments	3750000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	9223000
CY2021Q4	ater	Contingent Consideration Earn Out Payments ContingentConsiderationEarnOutPayments	3800000
CY2021Q4	ater	Common Stock Earn Out Payments CommonStockEarnOutPayments	1400000
CY2021	ater	Settlement Charge Of Contingent Earnout Liability SettlementChargeOfContingentEarnoutLiability	4200000
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	9223000
CY2022Q1	ater	Business Combination Contingent Consideration Change In Fair Value Of Contingent Earn Out Liabilities BusinessCombinationContingentConsiderationChangeInFairValueOfContingentEarnOutLiabilities	-2775000
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	6448000
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	29000000.0
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31944000
CY2021	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	40500000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72444000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5484000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7214000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7171000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7130000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7130000
CY2022Q1	ater	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	29082000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	63211000

Files In Submission

Name	View Source	Status
0001564590-22-019333-index-headers.html	Edgar Link	pending
0001564590-22-019333-index.html	Edgar Link	pending
0001564590-22-019333.txt	Edgar Link	pending
0001564590-22-019333-xbrl.zip	Edgar Link	pending
ater-10q_20220331.htm	Edgar Link	pending
ater-10q_20220331_htm.xml	Edgar Link	completed
ater-20220331.xsd	Edgar Link	pending
ater-20220331_cal.xml	Edgar Link	unprocessable
ater-20220331_def.xml	Edgar Link	unprocessable
ater-20220331_lab.xml	Edgar Link	unprocessable
ater-20220331_pre.xml	Edgar Link	unprocessable
ater-ex311_6.htm	Edgar Link	pending
ater-ex312_7.htm	Edgar Link	pending
ater-ex321_8.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATER
Aterian, Inc. Stock $ater

2022 Q1 Form 10-Q Financial Statement

#000156459022019333 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATER Aterian, Inc. Stock $ater

2022 Q1 Form 10-Q Financial Statement

#000156459022019333 Filed on May 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATER
Aterian, Inc. Stock $ater